InvestorsObserver
×
News Home

Is Precigen Inc (PGEN) a Stock to Watch This Week?

Wednesday, December 23, 2020 01:44 PM | InvestorsObserver Analysts

Mentioned in this article

Is Precigen Inc (PGEN) a Stock to Watch This Week?

Precigen Inc (PGEN) stock has gained 29.91% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
Precigen Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PGEN!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PGEN Stock Today?

Precigen Inc (PGEN) stock is lower by -7.38% while the S&P 500 has gained 0.65% as of 1:42 PM on Wednesday, Dec 23. PGEN is down -$0.77 from the previous closing price of $10.50 on volume of 1,169,973 shares. Over the past year the S&P 500 has gained 15.11% while PGEN has gained 61.36%. PGEN lost -$1.88 per share in the over the last 12 months.

To screen for more stocks like Precigen Inc click here.

More About Precigen Inc

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Click Here to get the full Stock Score Report on Precigen Inc (PGEN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App